Interní Med. 2009; 11(12): 573-578

Age-related macular degeneration, medication with the focus on biological therapy

MUDr.Zora Dubská, CSc.
Univerzita Karlova v Praze, 1. lékařská fakulta, Oční klinika 1. LF a VFN

Age-related macular degeneration (AMD) is the leading cause of severe central visual acuity loss in 1 or both eyes in people over 50 years

of age. The risk of AMD increases with age.

Keywords: macular degeneration, angiogenesis, angiography, treatment

Published: May 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Dubská Z. Age-related macular degeneration, medication with the focus on biological therapy. Interní Med. 2009;11(12):573-578.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Studnička J. Ranibizumab (Lucentis) v léčbě věkem podmíněné makulární degenerace. Čes. a Slov. Oftal. 2009, 65 (3): 107-111.
    2. Kolář P. a kol. Věkem podmíněná makulární degenerace. Praha: Grada Publishing, 2008, 145 s.
    3. Němec P. Optická koherenční tomografie. In: Kolář P. a kol. Věkem podmíněná makulární degenerace. Praha: Grada Publishing, 2008, 92-98.
    4. American academy of Ophthalmology Retina and Vitreous Basic and Clinical Science Course Section 12, 2009-2010, s. 61-90.
    5. Dubská Z. Indocyaninová angiografie. In: Kolář P. a kol. Věkem podmíněná makulární degenerace. Praha: Grada Publishing, 2008, s. 88-92.
    6. Coscas G, Coscas F, Zourdani A. Atlas d´angiographie en indocyanine: Confrontation FLUO-ICG-OCT. Rapport annuel - Novembre 2004. Bull. Soc. Ophtal Fr. 2004, 104: 118-179.
    7. Chrapek O, Řehák J. Fotodynamická terapie. In: Kolář P. a kol. Věkem podmíněná makulární degenerace. Praha: Grada Publishing, 2008, s. 100-105.
    8. Fišer I. Léčba věkem podmíněné makulární degenerace. New EU Magazine of medicine 3/4, 2008, s. 13-22.
    9. Guidelines pro léčbu věkem podmíněné makulární degenerace. Česká vitreoretinální společnost 2008. http://www.cvrs.cz/vpmd-guidlines.php.
    10. Ernest J. Chirurgická terapie VPMD. In: Kolář P. a kol. Věkem podmíněná makulární degenerace. Praha: Grada Publishing, 2008, s. 121-126.
    11. Clinical Trials. Gov. A service of the U.S. National Institues of Health OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration. http://www.clinicaltrials/ct/show/record/NCT00306488, 2009, s. 1-4.
    12. Rencová E, Bláha M, Blažek M, et al. Možnost ovlivnění suché formy věkem podmíněné na okulární degenerace hemorgeoferézou. Čes. A Slov. Oftal., 2009, 65 (2): 43-48.
    13. Regillo CD, Brown GC, Flynn HW. Vitreoretinal Disease. The Essentials. Thieme New York, Stuttgard 1999, s. 215.
    14. Kolář P. Věkem podmíněná makulární degenerace. Oftalmochirurgie 2008, 3 (2): 9-21.

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.